Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

Journal of Virology

Volumn 76, Issue 9, 2002, Pages 4559-4566

  Ried, Martin U ^a   Girod, Anne ^a   Leike, Kristin ^a   Büning, Hildegard ^a   Hallek, Michael ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; BETA1 INTEGRIN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN; PROTEIN A; STEM CELL FACTOR RECEPTOR; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD29; CAPSID; CELL LINE; DEPENDOVIRUS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULINS; LIGANDS; MUTAGENESIS, INSERTIONAL; PROTO-ONCOGENE PROTEINS C-KIT; RABBITS; RECEPTORS, CELL SURFACE; RECEPTORS, CXCR4; TRANSDUCTION, GENETIC;

EID: 0036229828     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.9.4559-4566.2002     Document Type: Article

References (34)

1. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3
2. 2 antibody
3. High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors
4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap
5. Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library
6. Genetic capsid modifications allow efficient re-targeting of adeno- associated virus type 2
7. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2
8. Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors
9. Recombinant adeno- associated virus (rAAV) vectors for somatic gene therapy: Recent advances and potential clinical applications
10. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors
11. Prospects for the use of adeno-associated virus as a vector for human gene therapy
12. Cloning of infectious adeno-associated virus genomes in bacterial plasmids
13. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells
14. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure
15. Retrovirus vectors displaying the lgG-binding domain of protein A
16. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A
17. + hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
18. Human fibroblast-growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
19. Building a better vector: The manipulation of AAV virions
20. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus
21. Modifying the host range properties of retroviral vectors
22. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
23. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus
24. MECI and MEC2: Two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation
25. Structural mimicry of a native protein by a minimized binding domain
26. AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
27. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
28. Subcellular compartmentalization of adeno-associated virus type 2 assembly
29. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2infection
30. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
31. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
32. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction
33. Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy
34. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield